ReviewSeminars in dialysis2018
Role of telehealth in renal replacement therapy education.
Review in Seminars in dialysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 23 citations in OpenAlex.
- Article
- The feasibility of integrating a home telehealth model for older persons living with hemodialysis.BMC geriatrics · 2024Article
- Can Telehealth Improve Access to Dietary Management in Patients Receiving Dialysis? Insights from Consumers.Nutrients · 2023Article
- Exploring the Potential of Chatbots in Critical Care Nephrology.Medicines (Basel, Switzerland) · 2023Review
- Chronic kidney disease and mobile health: quality of renal nutritional APPs in Italy.Acta bio-medica : Atenei Parmensis · 2023Review
- Article
- Development of an online patient decision aid for kidney failure treatment modality decisions.BMC nephrology · 2022Article
- Evaluation of the experience with the use of telemedicine in a home dialysis program-a qualitative and quantitative study.BMC nephrology · 2022Article
- Older adults and family caregivers' experience of digital health technology in frailty care: A systematic review and meta-ethnography protocol.HRB open research · 2022Article
- Management of Advanced Chronic Kidney Disease During the COVID-19 Pandemic: Suggestions From the Canadian Society of Nephrology COVID-19 Rapid Response Team.Canadian journal of kidney health and disease · 2020Article
- The need for renovating patient education in kidney transplantation: A qualitative study.Journal of education and health promotion · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The prevalence of end-stage renal disease is rising in the United States, which bears high financial and public health burden. The most common modality of renal replacement therapy (RRT) in the United States is in-center hemodialysis. Many patients report lack of comprehensive and timely education about their treatment options, which may preclude them from participating in home-based dialysis therapies and kidney transplantation evaluation. While RRT education has traditionally been provided in-person, the rise of telehealth has afforded new opportunities to improve upon the status quo. For example, technology-augmented RRT education has recently been implemented into telehealth nephrology clinics, informational websites and mobile applications maintained by professional organizations, patient-driven forums on social media, and multimodality programs. The benefits of technology in RRT education are increased access for geographically isolated and/or medically frail patients, versatility of content delivery, information repetition to enhance knowledge retention, and interpersonal connection for educational content and emotional support. Challenges center around privacy and accuracy of information sharing, in addition to differential access to technology due to age and socioeconomic status. A review of available scholarly and social media resources suggests that technology-aided delivery of education about treatment options for end-stage renal disease provides an important alternative and/or supplemental resource for patients and families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.